Global Cardiopulmonary Autotransfusion Systems Market Insights, Forecast to 2029

Publisher Name :
Date: 30-May-2023
No. of pages: 110
Inquire Before Buying

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The global Cardiopulmonary Autotransfusion Systems market is projected to grow from US$ 568.3 million in 2023 to US$ 655.2 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Report Includes:

This report presents an overview of global market for Cardiopulmonary Autotransfusion Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Cardiopulmonary Autotransfusion Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cardiopulmonary Autotransfusion Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cardiopulmonary Autotransfusion Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Cardiopulmonary Autotransfusion Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Cardiopulmonary Autotransfusion Systems sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources and Redax, etc.

By Company

- Advancis Surgical

- Fresenius Kabi

- Haemonetics

- LivaNova

- Medtronic

- Terumo

- Atrium Medical

- Global Blood Resources

- Redax

- Sarstedt

- Stryker

Segment by Type

- Unwashed ATS

- Washed ATS

Segment by Application

- Heart Surgery

- Great Organ Transplant Surgery

- Others

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Cardiopulmonary Autotransfusion Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiopulmonary Autotransfusion Systems sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Cardiopulmonary Autotransfusion Systems Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Cardiopulmonary Autotransfusion Systems Product Introduction
1.2 Market by Type
1.2.1 Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Autotransfusion Systems Sales Estimates and Forecasts 2018-2029
2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Region
2.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2018-2023)
2.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2024-2029)
2.2.4 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2018-2029)
2.3 Global Cardiopulmonary Autotransfusion Systems Sales Estimates and Forecasts 2018-2029
2.4 Global Cardiopulmonary Autotransfusion Systems Sales by Region
2.4.1 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Cardiopulmonary Autotransfusion Systems Sales by Region (2018-2023)
2.4.3 Global Cardiopulmonary Autotransfusion Systems Sales by Region (2024-2029)
2.4.4 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cardiopulmonary Autotransfusion Systems Sales by Manufacturers
3.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Manufacturers (2018-2023)
3.1.2 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cardiopulmonary Autotransfusion Systems in 2022
3.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Manufacturers
3.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Manufacturers (2018-2023)
3.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion Systems Revenue in 2022
3.3 Global Key Players of Cardiopulmonary Autotransfusion Systems, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Cardiopulmonary Autotransfusion Systems Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Product Offered and Application
3.8 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cardiopulmonary Autotransfusion Systems Sales by Type
4.1.1 Global Cardiopulmonary Autotransfusion Systems Historical Sales by Type (2018-2023)
4.1.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Sales by Type (2024-2029)
4.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2018-2029)
4.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Type
4.2.1 Global Cardiopulmonary Autotransfusion Systems Historical Revenue by Type (2018-2023)
4.2.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Revenue by Type (2024-2029)
4.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2018-2029)
4.3 Global Cardiopulmonary Autotransfusion Systems Price by Type
4.3.1 Global Cardiopulmonary Autotransfusion Systems Price by Type (2018-2023)
4.3.2 Global Cardiopulmonary Autotransfusion Systems Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Cardiopulmonary Autotransfusion Systems Sales by Application
5.1.1 Global Cardiopulmonary Autotransfusion Systems Historical Sales by Application (2018-2023)
5.1.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Sales by Application (2024-2029)
5.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Application (2018-2029)
5.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Application
5.2.1 Global Cardiopulmonary Autotransfusion Systems Historical Revenue by Application (2018-2023)
5.2.2 Global Cardiopulmonary Autotransfusion Systems Forecasted Revenue by Application (2024-2029)
5.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2018-2029)
5.3 Global Cardiopulmonary Autotransfusion Systems Price by Application
5.3.1 Global Cardiopulmonary Autotransfusion Systems Price by Application (2018-2023)
5.3.2 Global Cardiopulmonary Autotransfusion Systems Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Cardiopulmonary Autotransfusion Systems Market Size by Type
6.1.1 US & Canada Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2029)
6.1.2 US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2029)
6.2 US & Canada Cardiopulmonary Autotransfusion Systems Market Size by Application
6.2.1 US & Canada Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2029)
6.2.2 US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2029)
6.3 US & Canada Cardiopulmonary Autotransfusion Systems Market Size by Country
6.3.1 US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2029)
6.3.3 US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Type
7.1.1 Europe Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2029)
7.1.2 Europe Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2029)
7.2 Europe Cardiopulmonary Autotransfusion Systems Market Size by Application
7.2.1 Europe Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2029)
7.2.2 Europe Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2029)
7.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country
7.3.1 Europe Cardiopulmonary Autotransfusion Systems Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2029)
7.3.3 Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cardiopulmonary Autotransfusion Systems Market Size
8.1.1 China Cardiopulmonary Autotransfusion Systems Sales (2018-2029)
8.1.2 China Cardiopulmonary Autotransfusion Systems Revenue (2018-2029)
8.2 China Cardiopulmonary Autotransfusion Systems Market Size by Application
8.2.1 China Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2029)
8.2.2 China Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cardiopulmonary Autotransfusion Systems Market Size by Type
9.1.1 Asia Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2029)
9.1.2 Asia Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2029)
9.2 Asia Cardiopulmonary Autotransfusion Systems Market Size by Application
9.2.1 Asia Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2029)
9.2.2 Asia Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2029)
9.3 Asia Cardiopulmonary Autotransfusion Systems Sales by Region
9.3.1 Asia Cardiopulmonary Autotransfusion Systems Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Cardiopulmonary Autotransfusion Systems Revenue by Region (2018-2029)
9.3.3 Asia Cardiopulmonary Autotransfusion Systems Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Market Size by Type
10.1.1 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Market Size by Application
10.2.1 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Country
10.3.1 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Advancis Surgical
11.1.1 Advancis Surgical Company Information
11.1.2 Advancis Surgical Overview
11.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Advancis Surgical Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius Kabi Recent Developments
11.3 Haemonetics
11.3.1 Haemonetics Company Information
11.3.2 Haemonetics Overview
11.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Haemonetics Recent Developments
11.4 LivaNova
11.4.1 LivaNova Company Information
11.4.2 LivaNova Overview
11.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 LivaNova Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LivaNova Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Information
11.5.2 Medtronic Overview
11.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Medtronic Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Medtronic Recent Developments
11.6 Terumo
11.6.1 Terumo Company Information
11.6.2 Terumo Overview
11.6.3 Terumo Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Terumo Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Terumo Recent Developments
11.7 Atrium Medical
11.7.1 Atrium Medical Company Information
11.7.2 Atrium Medical Overview
11.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Atrium Medical Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Atrium Medical Recent Developments
11.8 Global Blood Resources
11.8.1 Global Blood Resources Company Information
11.8.2 Global Blood Resources Overview
11.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Global Blood Resources Recent Developments
11.9 Redax
11.9.1 Redax Company Information
11.9.2 Redax Overview
11.9.3 Redax Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Redax Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Redax Recent Developments
11.10 Sarstedt
11.10.1 Sarstedt Company Information
11.10.2 Sarstedt Overview
11.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Sarstedt Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sarstedt Recent Developments
11.11 Stryker
11.11.1 Stryker Company Information
11.11.2 Stryker Overview
11.11.3 Stryker Cardiopulmonary Autotransfusion Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Stryker Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Stryker Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cardiopulmonary Autotransfusion Systems Industry Chain Analysis
12.2 Cardiopulmonary Autotransfusion Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiopulmonary Autotransfusion Systems Production Mode & Process
12.4 Cardiopulmonary Autotransfusion Systems Sales and Marketing
12.4.1 Cardiopulmonary Autotransfusion Systems Sales Channels
12.4.2 Cardiopulmonary Autotransfusion Systems Distributors
12.5 Cardiopulmonary Autotransfusion Systems Customers
13 Market Dynamics
13.1 Cardiopulmonary Autotransfusion Systems Industry Trends
13.2 Cardiopulmonary Autotransfusion Systems Market Drivers
13.3 Cardiopulmonary Autotransfusion Systems Market Challenges
13.4 Cardiopulmonary Autotransfusion Systems Market Restraints
14 Key Findings in The Global Cardiopulmonary Autotransfusion Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Unwashed ATS
Table 3. Major Manufacturers of Washed ATS
Table 4. Global Cardiopulmonary Autotransfusion Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Cardiopulmonary Autotransfusion Systems Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2018-2023)
Table 9. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2024-2029)
Table 10. Global Cardiopulmonary Autotransfusion Systems Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Cardiopulmonary Autotransfusion Systems Sales by Region (2018-2023) & (K Units)
Table 12. Global Cardiopulmonary Autotransfusion Systems Sales by Region (2024-2029) & (K Units)
Table 13. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2018-2023)
Table 14. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2024-2029)
Table 15. Global Cardiopulmonary Autotransfusion Systems Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Cardiopulmonary Autotransfusion Systems Sales Share by Manufacturers (2018-2023)
Table 17. Global Cardiopulmonary Autotransfusion Systems Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Cardiopulmonary Autotransfusion Systems, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Cardiopulmonary Autotransfusion Systems Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Cardiopulmonary Autotransfusion Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Cardiopulmonary Autotransfusion Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2022)
Table 23. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Product Offered and Application
Table 25. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 28. Global Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 29. Global Cardiopulmonary Autotransfusion Systems Sales Share by Type (2018-2023)
Table 30. Global Cardiopulmonary Autotransfusion Systems Sales Share by Type (2024-2029)
Table 31. Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Type (2018-2023)
Table 34. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Type (2024-2029)
Table 35. Cardiopulmonary Autotransfusion Systems Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Cardiopulmonary Autotransfusion Systems Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 38. Global Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 39. Global Cardiopulmonary Autotransfusion Systems Sales Share by Application (2018-2023)
Table 40. Global Cardiopulmonary Autotransfusion Systems Sales Share by Application (2024-2029)
Table 41. Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Application (2018-2023)
Table 44. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Application (2024-2029)
Table 45. Cardiopulmonary Autotransfusion Systems Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Cardiopulmonary Autotransfusion Systems Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Cardiopulmonary Autotransfusion Systems Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Cardiopulmonary Autotransfusion Systems Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Cardiopulmonary Autotransfusion Systems Sales by Country (2024-2029) & (K Units)
Table 60. Europe Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 61. Europe Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 62. Europe Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 65. Europe Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 66. Europe Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Cardiopulmonary Autotransfusion Systems Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2023) & (K Units)
Table 72. Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2024-2029) & (K Units)
Table 73. China Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 74. China Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 75. China Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 78. China Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 79. China Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 82. Asia Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 83. Asia Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 86. Asia Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 87. Asia Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Cardiopulmonary Autotransfusion Systems Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Cardiopulmonary Autotransfusion Systems Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Cardiopulmonary Autotransfusion Systems Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Cardiopulmonary Autotransfusion Systems Sales by Region (2018-2023) & (K Units)
Table 93. Asia Cardiopulmonary Autotransfusion Systems Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2024-2029) & (K Units)
Table 107. Advancis Surgical Company Information
Table 108. Advancis Surgical Description and Major Businesses
Table 109. Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Advancis Surgical Recent Developments
Table 112. Fresenius Kabi Company Information
Table 113. Fresenius Kabi Description and Major Businesses
Table 114. Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Fresenius Kabi Recent Developments
Table 117. Haemonetics Company Information
Table 118. Haemonetics Description and Major Businesses
Table 119. Haemonetics Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Haemonetics Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Haemonetics Recent Developments
Table 122. LivaNova Company Information
Table 123. LivaNova Description and Major Businesses
Table 124. LivaNova Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. LivaNova Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. LivaNova Recent Developments
Table 127. Medtronic Company Information
Table 128. Medtronic Description and Major Businesses
Table 129. Medtronic Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Medtronic Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Medtronic Recent Developments
Table 132. Terumo Company Information
Table 133. Terumo Description and Major Businesses
Table 134. Terumo Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Terumo Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Terumo Recent Developments
Table 137. Atrium Medical Company Information
Table 138. Atrium Medical Description and Major Businesses
Table 139. Atrium Medical Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Atrium Medical Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Atrium Medical Recent Developments
Table 142. Global Blood Resources Company Information
Table 143. Global Blood Resources Description and Major Businesses
Table 144. Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Global Blood Resources Recent Developments
Table 147. Redax Company Information
Table 148. Redax Description and Major Businesses
Table 149. Redax Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Redax Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Redax Recent Developments
Table 152. Sarstedt Company Information
Table 153. Sarstedt Description and Major Businesses
Table 154. Sarstedt Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Sarstedt Cardiopulmonary Autotransfusion Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sarstedt Recent Developments
Table 157. Stryker Company Information
Table 158. Stryker Description and Major Businesses
Table 159. Stryker Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs